However, recent findings suggest that NRF2 may also act as a tumor promoter in specific cancers, particularly lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) [47]. The gene discussed is NFE2L2; the disease is neoplasm.